Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic's Revenues Tumble; Firm Continues to Mull Genomics Arm

NEW YORK (GenomeWeb News) — Gene Logic said today its first-quarter revenues fell 63 percent as R&D spending remained flat and net losses narrowed 17 percent.
 
Total receipts for the three months ended March 31 fell to $3.3 million from $8.7 million year over year.
 
All of the company’s revenue came from its genomics services business. Gene Logic reiterated that it has hired outside advisors to “assist in considering strategic alternatives” for its genomics business.
 
R&D was flat for the first quarter at $2.4 million.
 
The company said net losses decreased to $10.1 million from $11.8 million in the year-ago period.
 
As of March 31, Gene Logic had $27.4 million in combined cash and cash equivalents, and $15.7 million in marketable securities.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.